Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity and safety in peripheral T-cell lymphomas

Allen PB, Lechowicz MJ

Cancer Management and Research 2018, 10:6731-6742

Published Date: 6 December 2018